Website of the Department of Health
Please note that this website has a UK government access keys system.
Page menu
You are here:
Pharmaceutical Price Regulation Scheme
The National Health Service (NHS) spends about £9 billion a year on branded prescription medicines in the UK. The Pharmaceutical Price Regulation Scheme (PPRS) is the mechanism which the Department of Health (on behalf of the UK health departments) uses to ensure that the NHS has access to good quality branded medicines at reasonable prices. The scheme seeks to achieve a balance between reasonable prices for the NHS and a fair return for the industry to enable it to research, develop and market new and improved medicines.
Introduction to pharmaceutical price regulation
PPRS: What's new
2009 PPRS
PPRS reports to parliament
In 1994 the Health Committee recommended that the Department of Health introduce greater transparency into the PPRS by publishing an annual report on the scheme. The first report was published in 1996, and there has been one almost every year since.
PPRS: the study into the extent of competition in the supply of branded medicines to the NHS
Published: 01/12/2002
Following the 1999 PPRS agreement, a joint assessment by the Department of Health and the Association of the British Pharmaceutical Industry (ABPI) of the scope, pace of change and practical impact of competition in the supply and use of branded medicines for the NHS took place. The results of this study will be available to both the Government and the pharmaceutical industry in considering the future direction of policy on the PPRS.
PPRS contact
Access keys
